CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
500.66 -5.63(-1.11%) NAV as on 16 Jan 2026
-1.59 % 1 M
0.68 % 1 Y
21.11 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.82

As on 31 Dec, 2025
age-icon Age :

21 yrs 7 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,264.71 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.88

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2025
Others 2.63 %
Equity 97.37 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.02 %
Lupin Ltd.7.36 %
Divi's Laboratories Ltd.6.58 %
Cipla Ltd.6.39 %
Dr. Reddy's Laboratories Ltd.6.02 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs73.25
Hospital & Healthcare Services19.48
Retailing3.54
Business Support1.09
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 16-Jan-2026)290.14270.59428.87481.27500.66
Net Assets(Rs Crores) (as on 16-Jan-2026) 4931.89 4304.46 7125.28 8080.97 8264.71
Scheme Returns(%)(Absolute)14.83-6.8558.2410.945.61
B'mark Returns(%)(Absolute)NANANANANA
Category Rank43/7565/7617/9030/10278/113

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity500.66-5.63(-1.11%)NAV As on 16 Jan, 202605-Jun-2004Inception Date8,264.71AUM In Cr.0.68%1Y21.11%3Y14.17%5Y19.83%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.69-0.42(-1.07%)NAV As on 16 Jan, 202613-Jul-2018Inception Date6,455.55AUM In Cr.1.79%1Y26.35%3Y16.49%5Y19.72%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.46-0.30(-0.98%)NAV As on 16 Jan, 202610-Jul-2019Inception Date837.41AUM In Cr.0.86%1Y21.20%3Y12.74%5Y18.61%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors